|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-4-28
|
|
pubmed:abstractText |
To evaluate whether quantitative MRI parameters are sensitive to the effects of the tyrosine kinase inhibitor gefitinib and can discriminate between two different treatment protocols.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1053-1807
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1071-9
|
|
pubmed:dateRevised |
2011-1-24
|
|
pubmed:meshHeading |
pubmed-meshheading:19388114-Animals,
pubmed-meshheading:19388114-Antineoplastic Agents,
pubmed-meshheading:19388114-Breast Neoplasms,
pubmed-meshheading:19388114-Cell Line, Tumor,
pubmed-meshheading:19388114-Disease Models, Animal,
pubmed-meshheading:19388114-Dose-Response Relationship, Drug,
pubmed-meshheading:19388114-Drug Administration Schedule,
pubmed-meshheading:19388114-Female,
pubmed-meshheading:19388114-Humans,
pubmed-meshheading:19388114-Magnetic Resonance Imaging,
pubmed-meshheading:19388114-Mice,
pubmed-meshheading:19388114-Mice, Nude,
pubmed-meshheading:19388114-Outcome Assessment (Health Care),
pubmed-meshheading:19388114-Prognosis,
pubmed-meshheading:19388114-Protein Kinase Inhibitors,
pubmed-meshheading:19388114-Protein-Tyrosine Kinases,
pubmed-meshheading:19388114-Quinazolines
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model.
|
|
pubmed:affiliation |
Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, California 94107, USA. sheye.aliu@radiology.ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies,
Research Support, N.I.H., Extramural
|
